Cascade Continuous Glucose Monitor (CGM) 15-Day US Performance Assessment

NCT04397965 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2020-10-12

No results posted yet for this study

Summary

To assess a 15-day wear period of the Cascade Continuous Glucose Monitoring (CGM) System

Conditions

  • Continuous Glucose Monitoring

Interventions

DEVICE

Cascade Continuous Glucose Monitor

Continuous Glucose Monitoring

Sponsors & Collaborators

  • WaveForm Technologies Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-31
Primary Completion
2021-04-30
Completion
2021-05-31
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04397965 on ClinicalTrials.gov